Abstract
The management of intraoperative bleeding in children is challenging and requires thoughtful diagnostics and therapy. A reliable and effective concept for bleeding therapy should be based on timely coagulation testing (e.g. ROTEM®), but this should be adapted to local conditions and resources. Ideally, an interdisciplinary operating procedure should be prepared and all pediatric anesthesiologists should be trained to use it. This procedure may include prophylactic administration of tranexamic acid for high risk procedures, provision of a cell salvage device, and a detailed bleeding history (for all patients). As there is no evidence-based data on universal coagulation therapy using transfusion of fresh frozen plasma, targeted administration of purified coagulation factors might offer a fast and safe alternative. For instance, the most common intraoperative hemostasis disorders are caused by dilutional coagulopathy, with an underlying fibrinogen and/or FXIII deficiency, both of which can be effectively treated with purified coagulation factors. More severe bleeding episodes may also affect platelet count and thrombin building capacity, whereas hyperfibrinolysis is a rare event during major pediatric surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J (2011) Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev (3):CD007871
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70(1):165–172
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72(5):1651–1657
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80(8):1998–2005
Chee YL, Crawford JC, Watson HG, Greaves M (2008) Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 140(5):496–504
Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB (2008) Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 94(3):221–226
Dickneite G, Pragst I, Joch C, Bergman GE (2009) Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 20(7):535–540
Dirkmann D, Hanke AA, Gorlinger K, Peters J (2008) Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 106(6):1627–1632
Dzik WH (2004) Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 3(5):324–330
Ekert H, Brizard C, Eyers R, Cochrane A, Henning R (2006) Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 17(5):389–395
Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B (2008) Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 101(6):769–773
Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B (2009a) Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 7(5):795–802
Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B (2009b) Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 7(7):1099–1105
Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B (2010) Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 50(12):2571–2576
Fries D (2006) Dilutional coagulopathy: development, diagnostic options and management. Hamostaseologie 26(3 Suppl 1):S15–S19
Fries D, Innerhofer P, Perger P, Gutl M, Heil S, Hofmann N, Kneifel W, Neuner L, Pernerstorfer T, Pfanner G, Schochl H, Ziegler B, Kolblinger C, Kozek-Langenecker S (2010) Coagulation management in trauma-related massive bleeding.- Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI). Anasthesiol Intensivmed Notfallmed Schmerzther 45(9):552–561
Friesen RH, Perryman KM, Weigers KR, Mitchell MB, Friesen RM (2006) A trial of fresh autologous whole blood to treat dilutional coagulopathy following cardiopulmonary bypass in infants. Paediatr Anaesth 16(4):429–435
Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V (2002) Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33(6):1618–1623
Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114(4):862–871
Goobie SM, Meier PM, Sethna NF, Soriano SG, Zurakowski D, Samant S, Pereira LM (2013) Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery. Clin Pharmacokinet 52(4):267–276
Guzzetta NA, Miller BE (2011) Principles of hemostasis in children: models and maturation. Paediatr Anaesth 21(1):3–9
Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P (2008) Fibrinogen in craniosynostosis surgery. Anesth Analg 106(3):725–731
Haas T, Korte W, Spielmann N, Mauch J, Madjdpour C, Schmugge M, Weiss M (2012a) Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth 22(7):641–646
Haas T, Mauch J, Weiss M, Schmugge M (2012b) Management of dilutional coagulopathy during pediatric major surgery. Transfus Med Hemother 39(2):114–119
Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M (2012c) Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 108(1):36–41
Haas T, Spielmann N, Mauch J, Speer O, Schmugge M, Weiss M (2012d) Reproducibility of thrombelastometry (ROTEM((R))): point-of-care versus hospital laboratory performance. Scand J Clin Lab Invest 72(4):313–317
Hayashi T, Sakurai Y, Fukuda K, Yada K, Ogiwara K, Matsumoto T, Yoshizawa H, Takahashi Y, Yoshikawa Y, Hayata Y, Taniguchi S, Shima M (2011) Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 21(8):865–871
Heisel M, Nagib M, Madsen L, Alshiekh M, Bendel A (2004) Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. Pediatr Blood Cancer 43(6):703–705
Innerhofer P, Kienast J (2010) Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 24(1):1–14
Johansson PI, Ostrowski SR, Secher NH (2010) Management of major blood loss: an update. Acta Anaesthesiol Scand 54(9):1039–1049
Korte W (2006) Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy. Hamostaseologie 26(3 Suppl 1):S30–S35
Korte W (2010) F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 24(1):85–93
Korte WC, Szadkowski C, Gahler A, Gabi K, Kownacki E, Eder M, Degiacomi P, Zoller N, Devay J, Lange J, Schnider T (2009) Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 110(2):239–245
Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, Salama A, Kiesewetter H, Latza R (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10(2):155–166
Kozek-Langenecker S (2007) Management of massive operative blood loss. Minerva Anestesiol 73:401–415
Kozek-Langenecker SA (2010) Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 24(1):27–40
Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Gorlinger K, Haas T, Imberger G, Jacob M, Lance M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelso AJ, Wouters P, Wyffels P (2013) Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30(6):270–382
Kuhle S, Male C, Mitchell L (2003) Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost 29(4):329–338
Lavoie J (2011) Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 21(1):14–24
Levy JH (2006) Massive transfusion coagulopathy. Semin Hematol 43(1 Suppl 1):S59–S63
Levy JH, Szlam F, Tanaka KA, Sniecienski RM (2012) Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 114(2):261–274
Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P (2009) Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 7(12):2064–2069
Miller BE, Bailey JM, Mancuso TJ, Weinstein MS, Holbrook GW, Silvey EM, Tosone SR, Levy JH (1997) Functional maturity of the coagulation system in children: an evaluation using thrombelastography. Anesth Analg 84(4):745–748
Nielsen VG, Gurley WQ Jr, Burch TM (2004) The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 99(1):120–123
Osthaus WA, Witt L, Johanning K, Boethig D, Winterhalter M, Huber D, Heimbucher C, Suempelmann R (2009) Equal effects of gelatin and hydroxyethyl starch (6% HES 130/0.42) on modified thrombelastography in children. Acta Anaesthesiol Scand 53(3):305–310
Oswald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, Innerhofer P, Haas T (2010) Thromboelastometry (ROTEM(R)) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 105(6):827–835
Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M (2009) Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 138(3):694–702
Romlin BS, Wahlander H, Berggren H, Synnergren M, Baghaei F, Nilsson K, Jeppsson A (2011) Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg 112(1):30–36
Samkova A, Blatny J, Fiamoli V, Dulicek P, Parizkova E (2012) Significance and causes of abnormal preoperative coagulation test results in children. Haemophilia 18(3):e297–e301
Schochl H, Frietsch T, Pavelka M, Jambor C (2009) Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 67(1):125–131
Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14(2):R55
Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW (2009) The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 10(2):182–190
Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102(4):727–732
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C (2012) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev (3):CD005011
Sorensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C (2012) Fibrinogen as a hemostatic agent. Semin Thromb Hemost 38(3):268–273
Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R (2013) Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 17(2):R76
Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H (2008) HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol 25(6):437–445
Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF (2004) Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126(1):139–152
Stricker PA, Fiadjoe JE, Davis AR, Sussman E, Burgess BJ, Ciampa B, Mendelsohn J, Bartlett SP, Sesok-Pizzini DA, Jobes DR (2011) Reconstituted blood reduces blood donor exposures in children undergoing craniofacial reconstruction surgery. Paediatr Anaesth 21(1):54–61
Sumpelmann R, Kretz FJ, Luntzer R, de Leeuw TG, Mixa V, Gabler R, Eich C, Hollmann MW, Osthaus WA (2012) Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth 22(4):371–378
Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR (2010) In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 104(2):385–391
Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB (2008) Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev (3):CD006883
Uhrig L, Blanot S, Baugnon T, Orliaguet G, Carli PA, Meyer PG (2007) Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatr Crit Care Med 8(6):576–579
Weinkove R, Rangarajan S (2008) Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 18(3):151–157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haas, T. (2015). Perioperative Hemostasis in Pediatric Surgery. In: Marcucci, C., Schoettker, P. (eds) Perioperative Hemostasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55004-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-55004-1_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55003-4
Online ISBN: 978-3-642-55004-1
eBook Packages: MedicineMedicine (R0)